<--- Back to Details
First PageDocument Content
Health / European Medicines Agency / Summary of Product Characteristics / MedDRA / Adverse drug reaction / Adverse effect / Pseudoephedrine / Pharmacovigilance / Pharmacology / Pharmaceutical sciences / Medicine
Date: 2015-07-02 05:24:35
Health
European Medicines Agency
Summary of Product Characteristics
MedDRA
Adverse drug reaction
Adverse effect
Pseudoephedrine
Pharmacovigilance
Pharmacology
Pharmaceutical sciences
Medicine

Text of introduction - January 2013

Add to Reading List

Source URL: www.imi-protect.eu

Download Document from Source Website

File Size: 70,33 KB

Share Document on Facebook

Similar Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of

DocID: 1trcK - View Document

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.

DocID: 1tfLD - View Document

Pharmaceutical industry / Agencies of the European Union / Pharmaceuticals policy / Health / European Medicines Agency / European Union / Marketing authorization / Summary of Product Characteristics / Business

BPGWorksharingEMA-CMDv

DocID: 1rr9m - View Document

Pharmaceuticals policy / Health care / Health / Pharmaceutical industry / Medical research / Healthcare quality / European Medicines Agency / European Union / Qualified Person Responsible For Pharmacovigilance / Marketing authorization / Summary of Product Characteristics / Pharmacovigilance

B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDv

DocID: 1rcFm - View Document

Pharmaceutical sciences / Medicine / Biology / Botany / Pharmaceutics / Pharmacognosy / Phytotherapy / Herbalism / Summary of Product Characteristics / Pharmacology / Passiflora incarnata / Committee on Herbal Medicinal Products

5th World Congress on Medicinal and Aromatic Plants WOCMAP 2014 Brisbane (Australia), 17-20 August 2014 New developments from the European Scientific Cooperative on Phytotherapy

DocID: 1qSRs - View Document